rt-PA causes a dose-dependent increase in the extravasation of cellular and non-cellular blood elements after focal cerebral ischemia

Brain Research

Volumn 1164, Issue 1, 2007, Pages 55-62

  Burggraf, Dorothe ^a   Martens, Helge K ^a   Dichgans, Martin ^a   Hamann, Gerhard F ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

Basal lamina; Brain blood barrier, rt PA; Cerebral ischemia; Hemoglobin; MMP 9

Indexed keywords

ALTEPLASE; HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BLEEDING; BLOOD BRAIN BARRIER; BLOOD CELL; BLOOD COMPONENT; BODY WEIGHT; BRAIN ISCHEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; EDEMA; EXTRAVASATION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; STROKE; STROKE PATIENT; WESTERN BLOTTING;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CEREBRAL HEMORRHAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYTIC AGENTS; HEMOGLOBINS; MALE; MATRIX METALLOPROTEINASE 9; PROSENCEPHALON; RATS; RATS, WISTAR; REPERFUSION INJURY; TISSUE PLASMINOGEN ACTIVATOR;

RATTUS;

EID: 34547606766     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.05.066     Document Type: Article

References (31)

1. Belayev L., Busto R., Zhao W., and Ginsberg M.D. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 739 (1996) 88-96
2. Burggraf D., Martens H.K., Jager G., and Hamann G.F. Recombinant human tissue plasminogen activator protects the basal lamina in experimental focal cerebral ischemia. Thromb. Haemost. 89 (2003) 1072-1080
3. Burggraf D., Martens H.K., Liebetrau M., Vosko M.R., Dichgans M., and Hamann G.F. A new approach to reduce the number of animals used in experimental focal cerebral ischemia models. Neurosci. Lett. 386 (2005) 88-93
4. Busch E., Kruger K., and Hossmann K.A. Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat. Brain Res. 778 (1997) 16-24
5. Cherian P., Hankey G.J., Eikelboom J.W., Thom J., Baker R.I., McQuillan A., Staton J., and Yi Q. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. Stroke 34 (2003) 2132-2137
6. Dawson D.A., and Hallenbeck J.M. Acute focal ischemia-induced alterations in MAP2 immunostaining: description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury. J. Cereb. Blood Flow Metab. 16 (1996) 170-174
7. del Zoppo G.J. Microvascular changes during cerebral ischemia and reperfusion. Cerebrovasc. Brain Metab. Rev. 6 (1994) 47-96
8. Gasche Y., Fujimura M., Morita-Fujimura Y., Copin J.C., Kawase M., Massengale J., and Chan P.H. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab. 19 (1999) 1020-1028
9. Grobholz K., Burggraf D., Martens K.H., Wunderlich N., Pichler M., and Hamann G.F. Recombinant tissue plasminogen activator attenuates basal lamina antigen loss after experimental focal cerebral ischemia. Neurol. Res. 27 (2005) 212-217
10. Hamann G.F., Okada Y., and del Zoppo G.J. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J. Cereb. Blood Flow Metab. 16 (1996) 1373-1378
11. Hamann G.F., del Zoppo G.J., and von Kummer R. Hemorrhagic transformation of cerebral infarction-Possible mechanisms. Thromb. Haemost. 82 (1999) 92-94
12. Hamann G.F., del Zoppo G.J., and von Kummer R. Mechanisms for the development of intracranial hemorrhage. Possible implications for thrombolysis in cerebral infarct. Nervenarzt 70 (1999) 1116-1120
13. Hamann G.F., Liebetrau M., Martens H., Burggraf D., Kloss C.U., Bultemeier G., Wunderlich N., Jager G., and Pfefferkorn T. Microvascular basal lamina injury after experimental focal cerebral ischemia and reperfusion in the rat. J. Cereb. Blood Flow Metab. 22 (2002) 526-533
14. Karges H.E., Funk K.A., and Ronneberger H. Activity of coagulation and fibrinolysis parameters in animals. Arzneimittelforschung 44 (1994) 793-797
15. Kaur J., Zhao Z., Klein G.M., Lo E.H., and Buchan A.M. The neurotoxicity of tissue plasminogen activator?. J. Cereb. Blood Flow Metab. 24 (2004) 945-963
16. Kelly M.A., Shuaib A., and Todd K.G. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis. Exp. Neurol. 200 (2006) 38-49
17. Kloss C.U., Thomassen N., Fesl G., Martens K.H., Yousri T.A., and Hamann G.F. Tissue-saving infarct volumetry using histochemistry validated by MRI in rat focal ischemia. Neurol. Res. 24 (2002) 713-718
18. Liu J.K., and Rosenberg G.A. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic. Biol. Med. 39 (2005) 71-80
19. Miyazawa T., Bonnekoh P., and Hossmann K.-A. Temperature effect on immunostaining of microtubule-associated protein 2 and synaptophysin after 30 minutes of forebrain ischemia in rat. Acta Neuropathol. 85 (1993) 526-532
20. Neuwelt E.A. Implications of the Blood-Brain-Barrier and its Manipulation (1989), Plenum Press, New York
21. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, San Diego
22. Risau W., Esser S., and Engelhardt B. Differentiation of blood-brain barrier endothelial cells. Pathol. Biol. 46 (1998) 171-175
23. Rosenberg G.A. Ischemic brain edema. Prog. Cardiovasc. Dis. 42 (1999) 209-216
24. Rosenberg G.A., Estrada E.Y., and Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29 (1998) 2189-2195
25. Sheehan J.J., and Tsirka S.E. Fibrin-modifying serine proteases thrombin, tPA, and plasmin in ischemic stroke. Glia 50 (2005) 340-350
26. The national institute of neurological disorders and stroke rtPA Stroke Study Group. N. Engl. J. Med. 333 (1995) 1581-1587
27. Thiex R., Mayfrank L., Rohde V., Gilsbach J.M., and Tsirka S.A. The role of endogenous versus exogenous tPA on edema formation in murine ICH. Exp. Neurol. 189 (2004) 25-32
28. Tsuji K., Aoki T., Tejima E., Arai K., Lee S.R., Atochin D.N., Huang P.L., Wang X., Montaner J., and Lo E.H. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 36 (2005) 1954-1959
29. Wang X., Lee S.R., Arai K., Lee S.R., Tsuji K., Rebeck G.W., and Lo E.H. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat. Med. 9 (2003) 1313-1317
30. Yang G.Y., Betz A.L., Chenevert T.L., Brunberg J.A., and Hoff J.T. Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J. Neurosurg. 81 (1994) 93-102
31. Yepes M., Sandkvist M., Moore E.G., Bugge T.H., Strickland D.K., and Lawrence D.A. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest. 112 (2003) 1533-1540